Cao, Mugen, Qiuyan Lin, Liling Lin, Wenjie Zhang, and Lifeng Zhang. 2025. “The Efficacy and Safety of Empagliflozin in Elderly Patients With Type 2 Diabetes Mellitus Complicating Cardiorenal Syndromes Type II and IV: Evaluation of Empagliflozin in CRS”. Journal of Medical Biochemistry 44 (4): 905-14. https://doi.org/10.5937/jomb0-54743.